Documentos relacionados

1. A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome.
2. Ultrastructural analysis of nucleated erythrocyte in patients with autoimmune hemolytic anemia (AIHA).
3. Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double-blind, placebo-controlled, global study (FORWARD).
4. Outcomes of therapeutic plasma exchange in severe autoimmune hemolytic anemia hospitalizations: An analysis of the National Inpatient Sample.
5. The potential of metabolomics as a predictive guide for clinical management in autoimmunity against red blood cells.
6. Possible role of IL-23 inhibitor in autoimmune hemolytic anemia.
7. Survival in autoimmune hemolytic anemia remains poor, results from a nationwide cohort with 37 years of follow-up.
8. Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.
9. Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study.
10. Clinical perspectives, immunohematologic insights, and transfusion management in IgA-associated autoimmune hemolytic anemia.